Literature DB >> 6752019

Parenteral immunization with live respiratory syncytial virus is blocked in seropositive cotton rats.

G A Prince, R L Horswood, E Camargo, S C Suffin, R M Chanock.   

Abstract

Seropositive cotton rats cannot be immunized by intramuscular inoculation of live respiratory syncytial virus. Passively administered antiserum was shown to effect the immunosuppression. By contrast, the presence of serum antibody did not block immunization by the intranasal route.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6752019      PMCID： PMC347650          DOI： 10.1128/iai.37.3.1074-1078.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  13 in total

1.  Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: I. Viral shedding, immunologic response, and associated illness.

Authors:  L S Richardson; R B Belshe; W T London; D L Sly; D A Prevar; E Camargo; R M Chanock
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

2.  Further characterization of the complementation group B temperature-sensitive mutant of respiratory syncytial virus.

Authors:  R B Belshe; L S Richardson; T J Schnitzer; D A Prevar; E Camargo; R M Chanock
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

3.  Further investigations of live respiratory syncytial virus vaccine administered parenterally.

Authors:  E B Buynak; R E Weibel; A J Carlson; A A McLean; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1979-02

4.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Authors:  H W Kim; J G Canchola; C D Brandt; G Pyles; R M Chanock; K Jensen; R H Parrott
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

5.  An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.

Authors:  A Z Kapikian; R H Mitchell; R M Chanock; R A Shvedoff; C E Stewart
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

6.  Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population.

Authors:  J Chin; R L Magoffin; L A Shearer; J H Schieble; E H Lennette
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

7.  Live respiratory syncytial virus vaccine administered parenterally.

Authors:  E B Buynak; R E Weibel; A A McLean; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1978-04

8.  Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: II. Genetic analysis of virus recovered during infection.

Authors:  R B Belshe; L S Richardson; W T London; D L Sly; E Camargo; D A Prevar; R M Chanock
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

9.  The pathogenesis of respiratory syncytial virus infection in cotton rats.

Authors:  G A Prince; A B Jenson; R L Horswood; E Camargo; R M Chanock
Journal:  Am J Pathol       Date:  1978-12       Impact factor: 4.307

10.  Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine.

Authors:  V A Fulginiti; J J Eller; O F Sieber; J W Joyner; M Minamitani; G Meiklejohn
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897
View more
  7 in total

Review 1.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

2.  Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton rats.

Authors:  G A Prince; C Capiau; M Deschamps; L Fabry; N Garçon; D Gheysen; J P Prieels; G Thiry; O Van Opstal; D D Porter
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Age related IgG subclass response to respiratory syncytial virus fusion protein in infected infants.

Authors:  P J Watt; M Zardis; P R Lambden
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

4.  Passively acquired antibodies to respiratory syncytial virus impair the secondary cytotoxic T-cell response in the neonatal mouse.

Authors:  C R Bangham
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

5.  Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies.

Authors:  T G Kimman; F Westenbrink; B E Schreuder; P J Straver
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

Review 6.  A multifaceted approach to RSV vaccination.

Authors:  Jorge C G Blanco; Marina S Boukhvalova; Trudy G Morrison; Stefanie N Vogel
Journal:  Hum Vaccin Immunother       Date:  2018-06-19       Impact factor: 3.452

Review 7.  Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies.

Authors:  Stefan Niewiesk
Journal:  Front Immunol       Date:  2014-09-16       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.